Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»HealthCare»OMRON Healthcare releases new Women’s Heart Health Factbook
    HealthCare

    OMRON Healthcare releases new Women’s Heart Health Factbook

    Marie JonesBy Marie JonesMarch 9, 2026Updated:March 11, 2026No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email
    • International Women’s Day: Why Menopause May Be a Missed Cardiovascular Risk Window

    As International Women’s Day prompts renewed focus on women’s health, OMRON Healthcare has released a new Women’s Heart Health Factbook spotlighting an often-overlooked issue: the intersection between menopause, hypertension, and long-term cardiovascular risk.

    An estimated 32% of women aged 30-79 worldwide are living with hypertension. Yet only 59% are diagnosed, and just 23% achieve effective blood pressure control. That equates to less than a quarter of hypertensive women managing to stabilise their blood pressure.

    Cardiovascular disease remains the leading cause of death in women globally, with ischemic heart disease and stroke accounting for the majority of cases. Risk often accelerates during and after menopause, as declining estrogen levels affect vascular health and blood pressure regulation.

    Women also face additional life-stage factors that may influence cardiovascular outcomes, including pregnancy-related hypertension and hormonal contraceptive use, underscoring the importance of consistent monitoring across the lifespan.

    Expert perspective
    “Despite being the leading cause of death for women globally, cardiovascular disease is frequently underdiagnosed and undertreated in women due to longstanding biases in research, clinical guidelines and symptom recognition,” said Prof. Alta Schutte, Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine and Health at UNSW Sydney, Australia.

    “Menopause is not only a major life transition – it is also a cardiovascular turning point,” added Karel Herberigs, Managing Director, OMRON Healthcare EMEA. “Greater awareness and routine monitoring can help close a persistent care gap and support earlier intervention.”

    Archanna Mohangoo, Medical Marketing Manager (EMEA), said: “Too often, symptoms such as fatigue, disrupted sleep, or heart palpitations are attributed solely to menopause, when they may in some cases signal underlying conditions such as hypertension or atrial fibrillation (AFib), which can significantly increase stroke and heart disease risk if left undetected. This Factbook aims to encourage women and healthcare providers alike to look more closely at cardiovascular health during this stage of life.”

    Potential coverage angles
    – The global hypertension care gap in women
    – Menopause as a cardiovascular risk inflection point
    – Why blood pressure monitoring should remain a priority beyond reproductive years
    – The under-recognised burden of heart disease in women
    – Prevention and early detection strategies across the lifespan

    The Women’s Heart Health Factbook is available to download:  https://brandportal.healthcare.omron.com/share/365D593E-78F0-4F35-9C8A589508CB5951/

    Interviews, expert commentary, or additional data:
    omronhealthcare-pr@kyodo-pr.co.jp

    OMRON Corporation
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleWorld’s largest one stop jewellery marketplace attracts some 80,000 buyers, with growth in buyers from ASEAN, Korea and beyond
    Next Article Fosun International: One-Off Non-Cash Impairment Provisions for Certain Non-Core Businesses, Core Industries Maintain Sound Development Momentum

    Related Posts

    CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth

    October 27, 2026

    Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

    October 27, 2026

    Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization

    October 27, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Latest News

    • OMP Extends UnisonIQ with Agent Library and Agent Studio: AI Agents that Produce Executable Supply Chain Plans
    • DesignInspire opens on 18 November with free admission to the public on 19-21 November
    • FWD Group reports strong new business profitability growth
    • Chervon Names Jody Grimsley Senior National Account Manager
    • Chervon Promotes Soobia Haroon to Vice President, Human Resources – NA
    • Chervon Names Thomas Scherer Vice President of Organizational Development – Sales, End User Marketing, and Service
    • BIP Asia Forum and Entrepreneur Day set for November
    • COSCO SHIPPING Ports Receives Two Accolades at the HKMA 2026 Best Annual Reports Awards, with SynTao Green Finance ESG Rating Simultaneously Upgraded to ‘A’
    • SAP Helps CHKP Group Connect Online and Offline Retail to Deliver Personalised Experiences at AV Life and FOTOMAX
    • MicroVision Expands Collaboration with FieldAI Across Government and Industrial Autonomous Systems Programs
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.